Stop TB’s Global Drug Facility Announces 38% Price Decrease for BPaLMRegimen and Newly-Available Drug-Sensitivity Tests

Updated: Mar 13

The Stop TB Partnership announced a major price reduction on bedaquiline. The cost per

treatment course was slashed by over 50%, resulting in a new cost of 90 USD. This

decrease brings the BPaLM regimen down to 364 USD per treatment course. This price

reduction will make treatment more accessible. Read more here.

Recent Posts

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...

The meeting of the WHO Accelerator Platform for Novel TB Regimens will be held on Thursday, 8 May 2025, from 14.00 to 15.30 (CET). Main...

The WHO released comprehensive guidelines for TB this week and shared important new updates to treatment options for MDR-TB. In...